ICAM1 and epilepsy: While some studies have not found significant differences in serum ICAM-1 levels in interictal epilepsy patients compared to controls [25], others suggest an upregulation of ICAM-1 and other adhesion molecules (e.g., VCAM) in epileptic patients, indicating increased BBB permeability [26].